These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4947831)

  • 1. WHO co-ordinated short-term double-blind trial with thalidomide in the treatment of acute lepra reactions in male lepromatous patients.
    Iyer CG; Languillon J; Ramanujam K; Tarabini-Castellani G; De las Aguas JT; Bechelli LM; Uemura K; Martinez Dominguez V; Sundaresan T
    Bull World Health Organ; 1971; 45(6):719-32. PubMed ID: 4947831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of a double blind study of the influence of thalidomide on the lepra reaction.
    Sheskin J; Convit J
    Int J Lepr Other Mycobact Dis; 1969; 37(2):135-46. PubMed ID: 4900407
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide in type-2 lepra reaction--a clinical experience.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1990; 62(3):316-20. PubMed ID: 2262716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [World survey on the use of thalidomide in leprosy reaction].
    Sheskin J; Sagher F
    Med Cutan Ibero Lat Am; 1975; 3(1):81-3. PubMed ID: 1240562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in leprosy--study of 94 cases.
    Parikh DA; Ganapati R; Revankar CR
    Indian J Lepr; 1986; 58(4):560-6. PubMed ID: 3572098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide in the treatment of lepra reactions.
    De las Aguas JT
    Int J Lepr Other Mycobact Dis; 1971; 39(2):593-7. PubMed ID: 4948095
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
    Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide: new preparation. For well-defined indications.
    Prescrire Int; 1998 Oct; 7(37):131-4. PubMed ID: 10848043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open trial with clofazimine in the management of recurrent lepra reaction using thalidomide as a control drug.
    Iyer CG; Ramu G
    Lepr India; 1976 Oct; 48(4 Suppl):690-4. PubMed ID: 1026805
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
    Ramu G; Girdhar A
    Lepr India; 1979 Oct; 51(4):497-504. PubMed ID: 522443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A trial of thalidomide in progressive lepra reactions.
    Cazort RJ; Ye Kun Song
    Curr Ther Res Clin Exp; 1966 Jun; 8(6):299-311. PubMed ID: 4956514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with thalidomide in 2 patients with acute lepromatous leprosy reactions].
    Hogerzeil LM; Simons RD
    Ned Tijdschr Geneeskd; 1966 Sep; 110(39):1722-3. PubMed ID: 5977696
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of leprosy: science or politics?
    Naafs B
    Trop Med Int Health; 2006 Mar; 11(3):268-78. PubMed ID: 16553906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Motor-conduction velocity of cubital nerves in patients with leprosy reactions. Summary of a 13-year observation series during thalidomide therapy].
    Sheskin J; Yaar I
    Hautarzt; 1979 Jul; 30(7):376-9. PubMed ID: 478858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic experience on the effect of thalidomidomide on lepra reaction].
    Sheskin J
    Hautarzt; 1975 Jan; 26(1):1-5. PubMed ID: 1090562
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide--effect on T cell subsets as a possible mechanism of action.
    Moncada B; Baranda ML; González-Amaro R; Urbina R; Loredo CE
    Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):201-5. PubMed ID: 3874920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of the leprosy reaction with thalidomide. (A double-blind study). Preliminary report].
    Sheskin J
    Hautarzt; 1966 Dec; 17(12):548-9. PubMed ID: 4869906
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.
    Drenth JP; Vonk AG; Simon A; Powell R; van der Meer JW
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1221-6. PubMed ID: 11504824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trial with CIBA 1906 in lepromatous leprosy.
    Anand LC; Tiwari VD; Rathore BS; Singh O
    Lepr India; 1981 Apr; 53(2):278-84. PubMed ID: 7019567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.